NCT00523406View on ClinicalTrials.gov

Comparison of Reduced Fluence Versus Standard Photodynamic Therapy (in Combination With Intravitreal Triamcinolone Acetate)

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Macular Degeneration
Interventions
PROCEDURE

Photodynamic therapy and intravitreal triamcinolone

combination of photodynamic therapy and intravitreal triamcinolone combination to treat neovascular AMD

Trial Locations (1)

1090

Medical University of Vienna, Department of Ophthalmology, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT00523406 - Comparison of Reduced Fluence Versus Standard Photodynamic Therapy (in Combination With Intravitreal Triamcinolone Acetate) | Biotech Hunter | Biotech Hunter